vs
iQSTEL Inc（IQST）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
iQSTEL Inc的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$84.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -3.2%，领先387.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -14.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 28.0%）
iQSTEL Inc是一家科技控股企业，业务覆盖电信、物联网与金融科技三大核心领域，面向南北美洲市场的中小企业及零售用户提供高性价比的通信服务、智能物联网监测解决方案及数字化金融工具。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
IQST vs RIGL — 直观对比
营收规模更大
IQST
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出36.1%
-14.9%
净利率更高
RIGL
高出387.2%
-3.2%
两年增速更快
RIGL
近两年复合增速
28.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $84.2M | $69.8M |
| 净利润 | $-2.7M | $268.1M |
| 毛利率 | 3.5% | 91.5% |
| 营业利润率 | -2.9% | 33.2% |
| 净利率 | -3.2% | 384.0% |
| 营收同比 | -14.9% | 21.2% |
| 净利润同比 | -44.5% | 1769.2% |
| 每股收益（稀释后） | $-0.92 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IQSTRIGL
| Q4 25 | $84.2M | $69.8M | ||
| Q3 25 | $102.9M | $69.5M | ||
| Q2 25 | $72.2M | $101.7M | ||
| Q1 25 | $57.6M | $53.3M | ||
| Q4 24 | $98.9M | $57.6M | ||
| Q3 24 | $54.2M | $55.3M | ||
| Q2 24 | $78.6M | $36.8M | ||
| Q1 24 | $51.4M | $29.5M |
净利润IQSTRIGL
| Q4 25 | $-2.7M | $268.1M | ||
| Q3 25 | $-2.3M | $27.9M | ||
| Q2 25 | $-2.3M | $59.6M | ||
| Q1 25 | $-1.1M | $11.4M | ||
| Q4 24 | $-1.9M | $14.3M | ||
| Q3 24 | $-773.0K | $12.4M | ||
| Q2 24 | $-2.0M | $-1.0M | ||
| Q1 24 | $-580.2K | $-8.2M |
毛利率IQSTRIGL
| Q4 25 | 3.5% | 91.5% | ||
| Q3 25 | 2.7% | 93.2% | ||
| Q2 25 | 2.6% | 95.6% | ||
| Q1 25 | 3.4% | 91.7% | ||
| Q4 24 | 2.7% | 89.9% | ||
| Q3 24 | 3.7% | 85.5% | ||
| Q2 24 | 2.8% | 92.4% | ||
| Q1 24 | 2.7% | 93.1% |
营业利润率IQSTRIGL
| Q4 25 | -2.9% | 33.2% | ||
| Q3 25 | -0.5% | 40.9% | ||
| Q2 25 | -0.9% | 60.1% | ||
| Q1 25 | -1.0% | 23.9% | ||
| Q4 24 | -0.3% | 28.9% | ||
| Q3 24 | -0.1% | 25.4% | ||
| Q2 24 | -0.4% | 1.2% | ||
| Q1 24 | -0.4% | -23.6% |
净利率IQSTRIGL
| Q4 25 | -3.2% | 384.0% | ||
| Q3 25 | -2.3% | 40.2% | ||
| Q2 25 | -3.3% | 58.6% | ||
| Q1 25 | -2.0% | 21.5% | ||
| Q4 24 | -1.9% | 24.9% | ||
| Q3 24 | -1.4% | 22.5% | ||
| Q2 24 | -2.5% | -2.8% | ||
| Q1 24 | -1.1% | -27.9% |
每股收益（稀释后）IQSTRIGL
| Q4 25 | $-0.92 | $14.11 | ||
| Q3 25 | $-0.68 | $1.46 | ||
| Q2 25 | $-0.82 | $3.28 | ||
| Q1 25 | $-0.44 | $0.63 | ||
| Q4 24 | $-1.19 | $0.82 | ||
| Q3 24 | $-0.40 | $0.70 | ||
| Q2 24 | $-0.90 | $-0.06 | ||
| Q1 24 | $-0.37 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.2M | $155.0M |
| 总债务越低越好 | $4.1M | $52.5M |
| 股东权益账面价值 | $16.3M | $391.5M |
| 总资产 | $51.1M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.25× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资IQSTRIGL
| Q4 25 | $2.2M | $155.0M | ||
| Q3 25 | $2.3M | $137.1M | ||
| Q2 25 | $2.0M | $108.4M | ||
| Q1 25 | $1.1M | $77.1M | ||
| Q4 24 | $2.5M | $77.3M | ||
| Q3 24 | $2.1M | $61.1M | ||
| Q2 24 | $797.2K | $49.1M | ||
| Q1 24 | $2.7M | $49.5M |
总债务IQSTRIGL
| Q4 25 | $4.1M | $52.5M | ||
| Q3 25 | $2.7M | $60.0M | ||
| Q2 25 | $4.5M | $60.0M | ||
| Q1 25 | $3.5M | $60.0M | ||
| Q4 24 | $2.5M | $60.0M | ||
| Q3 24 | $3.2M | $60.0M | ||
| Q2 24 | $2.5M | $60.0M | ||
| Q1 24 | $194.0K | $60.0M |
股东权益IQSTRIGL
| Q4 25 | $16.3M | $391.5M | ||
| Q3 25 | $17.9M | $117.6M | ||
| Q2 25 | $14.3M | $81.9M | ||
| Q1 25 | $11.6M | $18.6M | ||
| Q4 24 | $11.9M | $3.3M | ||
| Q3 24 | $8.1M | $-14.6M | ||
| Q2 24 | $7.6M | $-29.9M | ||
| Q1 24 | $8.4M | $-31.7M |
总资产IQSTRIGL
| Q4 25 | $51.1M | $513.6M | ||
| Q3 25 | $46.9M | $242.5M | ||
| Q2 25 | $51.4M | $206.7M | ||
| Q1 25 | $42.0M | $176.0M | ||
| Q4 24 | $79.0M | $164.0M | ||
| Q3 24 | $32.4M | $139.4M | ||
| Q2 24 | $30.0M | $128.4M | ||
| Q1 24 | $22.1M | $126.5M |
负债/权益比IQSTRIGL
| Q4 25 | 0.25× | 0.13× | ||
| Q3 25 | 0.15× | 0.51× | ||
| Q2 25 | 0.31× | 0.73× | ||
| Q1 25 | 0.31× | 3.23× | ||
| Q4 24 | 0.21× | 18.25× | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.2M | — |
| 自由现金流率自由现金流/营收 | -1.5% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-4.0M | — |
8季度趋势，按日历期对齐
经营现金流IQSTRIGL
| Q4 25 | $-1.2M | $22.0M | ||
| Q3 25 | $-953.0K | $24.0M | ||
| Q2 25 | $257.7K | $30.5M | ||
| Q1 25 | $-1.9M | $-893.0K | ||
| Q4 24 | $-403.7K | $14.5M | ||
| Q3 24 | $625.0K | $21.7M | ||
| Q2 24 | $-2.6M | $302.0K | ||
| Q1 24 | $-536.9K | $-5.0M |
自由现金流IQSTRIGL
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-969.2K | — | ||
| Q2 25 | $211.7K | — | ||
| Q1 25 | $-2.0M | — | ||
| Q4 24 | $-421.3K | — | ||
| Q3 24 | $594.5K | — | ||
| Q2 24 | $-2.6M | — | ||
| Q1 24 | $-608.5K | — |
自由现金流率IQSTRIGL
| Q4 25 | -1.5% | — | ||
| Q3 25 | -0.9% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | -3.4% | — | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | -3.4% | — | ||
| Q1 24 | -1.2% | — |
资本支出强度IQSTRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率IQSTRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
RIGL
暂无分部数据
